Back to Search
Start Over
IMMUNE AND VIRUS‐SPECIFIC RESPONSES IN PARTICIPANTS WITH PRIMARY EFFUSION LYMPHOMA RECEIVING LENALIDOMIDE, DOSE‐ADJUSTED EPOCH, AND RITUXIMAB (EPOCH‐R2)
- Source :
- Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 02780232
- Volume :
- 39
- Database :
- Complementary Index
- Journal :
- Hematological Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 150947554
- Full Text :
- https://doi.org/10.1002/hon.5_2880